CEBP Frontiers in Cancer Prevention Research - 2008 Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bosch, F. X.
Right arrow Articles by Larranaga, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bosch, F. X.
Right arrow Articles by Larranaga, I.

Cancer Epidemiology Biomarkers & Prevention, Vol 2, Issue 5 415-422, Copyright © 1993 by American Association for Cancer Research


ARTICLES

Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia

FX Bosch, N Munoz, S de Sanjose, C Navarro, P Moreo, N Ascunce, LC Gonzalez, L Tafur, M Gili and I Larranaga
International Agency for Research on Cancer, Lyon, France.

A case-control study of 525 cases of cervical intraepithelial neoplasia grade III (CIN III) and 512 controls was conducted in Spain and Colombia between 1985 and 1988 to assess the role of human papillomavirus (HPV) in the etiology of CIN III. HPV DNA in cytological scrapes from the cervix was assessed by Virapap and by polymerase chain reaction (PCR) based on the L1 consensus primers. A subsample of 268 specimens was also tested for HPV DNA using Southern hybridization. In Spain, the PCR-based prevalences of HPV DNA were 70.7% among cases and 4.7% among controls. Odds ratio (OR) and 95% confidence interval (numbers in parentheses) for HPV DNA were 56.9 (24.8-130.6). In Columbia HPV DNA was detected by PCR in 63.2% of the cases and in 10.5% of the controls. The OR was 15.5 (8.2-29.4). The estimated fractions of CIN III attributable to HPV were 72.4% in Spain and 60.3% in Colombia. HPV 16 was the predominant viral type and showed the strongest association with CIN III; in Spain the OR was 295.5 (44.8-1946.4) and in Colombia the OR was 27.1 (10.6-69.5). HPV DNA of unknown type was frequent in HPV-positive cases (18.3% in Spain and 38.0% in Colombia) and controls (66.7% in Spain and 47.4% in Colombia). The comparison of results from Virapap and PCR indicated that PCR is the method of choice for epidemiological studies. These data strongly support the hypothesis of the viral origin of CIN III, the common etiology of CIN III and invasive cervical cancer, and the causal nature of the association between HPV and CIN III.


This article has been cited by other articles:


Home page
Am J EpidemiolHome page
X. Castellsague, R. W. Peeling, S. Franceschi, S. de Sanjose, J. S. Smith, G. Albero, M. Diaz, R. Herrero, N. Munoz, F. X. Bosch, et al.
Chlamydia trachomatis Infection in Female Partners of Circumcised and Uncircumcised Adult Men
Am. J. Epidemiol., November 1, 2005; 162(9): 907 - 916.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
C Carrilho, L Cirnes, M Alberto, L Buane, N Mendes, and L David
Distribution of HPV infection and tumour markers in cervical intraepithelial neoplasia from cone biopsies of Mozambican women
J. Clin. Pathol., January 1, 2005; 58(1): 61 - 68.
[Abstract] [Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
M Molano, E Weiderpass, H Posso, S A Morre, M Ronderos, S Franceschi, A Arslan, C J L M Meijer, N Munoz, and A J C van den Brule
Prevalence and determinants of Chlamydia trachomatis infections in women from Bogota, Colombia
Sex. Transm. Inf., December 1, 2003; 79(6): 474 - 478.
[Abstract] [Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
S de Sanjose, F X Bosch, L A Tafur, C M Nascimento, I Izarzugaza, A Izquierdo, A Barricarte, K V Shah, C J L M Meijer, and N Munoz
Clearance of HPV infection in middle aged men and women after 9 years' follow up
Sex. Transm. Inf., August 1, 2003; 79(4): 348 - 348.
[Full Text] [PDF]


Home page
NEJMHome page
N. Munoz, F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J.F. Snijders, C. J.L.M. Meijer, and the International Agency for Research on Cancer Mu
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
N. Engl. J. Med., February 6, 2003; 348(6): 518 - 527.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
X. Castellsague, F. X. Bosch, N. Munoz, C. J.L.M. Meijer, K. V. Shah, S. de Sanjose, J. Eluf-Neto, C. A. Ngelangel, S. Chichareon, J. S. Smith, et al.
Male Circumcision, Penile Human Papillomavirus Infection, and Cervical Cancer in Female Partners
N. Engl. J. Med., April 11, 2002; 346(15): 1105 - 1112.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
A. Touze, S. de Sanjose, P. Coursaget, M. R. Almirall, V. Palacio, C. J. L. M. Meijer, J. Kornegay, and F. X. Bosch
Prevalence of Anti-Human Papillomavirus Type 16, 18, 31, and 58 Virus-Like Particles in Women in the General Population and in Prostitutes
J. Clin. Microbiol., December 1, 2001; 39(12): 4344 - 4348.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
D. B. Thomas, Q. Qin, J. Kuypers, N. Kiviat, R. L. Ashley, A. Koetsawang, R. M. Ray, and S. Koetsawang
Human Papillomaviruses and Cervical Cancer in Bangkok. II. Risk Factors for in Situ and Invasive Squamous Cell Cervical Carcinomas
Am. J. Epidemiol., April 15, 2001; 153(8): 732 - 739.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
R. Herrero, A. Hildesheim, C. Bratti, M. E. Sherman, M. Hutchinson, J. Morales, I. Balmaceda, M. D. Greenberg, M. Alfaro, R. D. Burk, et al.
Population-Based Study of Human Papillomavirus Infection and Cervical Neoplasia in Rural Costa Rica
J Natl Cancer Inst, March 15, 2000; 92(6): 464 - 474.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
P. E. Gravitt, C. L. Peyton, R. J. Apple, and C. M. Wheeler
Genotyping of 27 Human Papillomavirus Types by Using L1 Consensus PCR Products by a Single-Hybridization, Reverse Line Blot Detection Method
J. Clin. Microbiol., October 1, 1998; 36(10): 3020 - 3027.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.